APEX-AMI - Pexelizumab in Conjunction With Angioplasty

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 22 Nov 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Aug 2023 Results comparing 15-year mortality of ST elevation myocardial infarction of Canadian (STEMI) patients with high-risk electrocardiographic findings enrolled within 6 hours of symptom onset undergoing primary PCI, presented at the ESC Congress 2023 - Annual Congress of the European Society of Cardiology
09 Nov 2019 Results(n=683) of exploratory analysis assessing associations between SR in ST-segment elevation myocardial infarction (STEMI) using a multimarker cardiovascular proteins strategypublished in the American Heart Journal.
13 Feb 2008 Status changed from in progress to completed according to ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com